Filtered By:
Procedure: Angiography

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 31979 results found since Jan 2013.

The effect of trimetazidine on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention - A systematic review and meta-analysis
CONCLUSIONS: Trimetazidine administration decreases the risk of CIN in patients undergoing CAG/PCI.PMID:33877668 | DOI:10.26355/eurrev_202104_25558
Source: European Review for Medical and Pharmacological Sciences - April 20, 2021 Category: Drugs & Pharmacology Authors: J W Martha R Pranata A Wibowo I Irvan R Afrianti M R Akbar Source Type: research

The role of pentoxifylline in preventing contrast-induced nephropathy in coronary angiography/intervention - systematic review, meta-analysis, and meta-regression of randomized controlled trials
CONCLUSIONS: Our meta-analysis showed that pentoxifylline was not associated with the risk of CIN with low certainty of evidence. Hence, larger, multicentre, double-blind randomized controlled trials are required.PMID:35587083 | DOI:10.26355/eurrev_202205_28750
Source: European Review for Medical and Pharmacological Sciences - May 19, 2022 Category: Drugs & Pharmacology Authors: J W Martha R Pranata W M Raffaello A Wibowo M R Akbar Source Type: research

A literature review of hypertensive retinopathy: systemic correlations and new technologies
CONCLUSIONS: The eye is the only organ in the human body where changes in the blood vessels due to systemic hypertension can be studied in vivo. All doctors should be familiar with this disease because it has been largely demonstrated that signs of HR are correlated to patient's health and mortality. Researchers should develop a new common, standardized, and objective method to assess hypertensive retinal changes; new technologies may have a significant role in this field. This review takes most of the literature published so far, including the OCTA studies in order to stimulate new points of reference to standardize param...
Source: European Review for Medical and Pharmacological Sciences - October 5, 2022 Category: Drugs & Pharmacology Authors: E Di Marco F Aiello M Lombardo M Di Marino F Missiroli R Mancino F Ricci C Nucci A Noce N Di Daniele M Cesareo Source Type: research